Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00352859
Status:
TERMINATED
Last Update Posted:
2014-12-30
First Post:
2006-07-14
Brief Title:
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-14
First Submit QC Date:
July 14 2006
Study First Post Date:
2006-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-26
Last Update Post Date:
2014-12-30
Last Update Post Date Type:
ESTIMATED